Soligenix Q3 2026 net loss narrows 56% to $1.1 million
Bitget2026/11/06 12:31- Soligenix's third-quarter net loss narrowed 56% year over year to $1.1 million, with no revenue.
- Research and development expenses fell 75% to $400,000 due to lower costs for the terminated FLASH2 trial and related HyBryte development.
- Approximately $9 million in cash and cash equivalents at September 30, 2026, should fund operations into the second quarter of 2028.
- Management is evaluating partnerships, licensing and potential mergers and acquisitions while advancing its rare-disease pipeline.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WLFI: Token buyback will be carried out on Aster through a public wallet
Layer 33 calls for a pause on removing validators under the new Solana Foundation regulations
HIVE’s Bitcoin output jumps 49%, but mining revenue still falls
Asia-Pacific stock markets follow the overnight rally in US tech stocks, with South Korea's KOSPI up 5% at the open, SK Hynix surging more than 7%, and Nikkei 225 rising over 2%.
This round of rebound occurred after the market experienced severe turbulence. Last week, concerns over the potential for stricter regulation of the artificial intelligence industry, due to the US Congressional election results, triggered a large-scale sell-off in chip stocks. Several market participants believe that this rebound indicates investors have not abandoned the AI trading narrative, and last week’s sell-off was more about position adjustments rather than a trend reversal.
Crypto prices
More
